Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Search for serum biomarkers in patients with bipolar disorder and major depressive disorder using metabolome analysis

6 Sept 2023

Abstract excerpt

Objective Bipolar disorder (BD) and major depressive disorder (MDD) are two common psychiatric disorders. Due to the overlapping clinical symptoms and the lack of objective diagnostic biomarkers, bipolar disorder (BD) is easily misdiagnosed as major depressive disorder (MDD), which in turn affects treatment decisions and prognosis. This study aimed to investigate biomarkers that could be used to differentiate BD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bipolar Disorder and Treatment
Share to Metabolomics and Mass Spectrometry Studies
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37736060
DOI: 10.3389/fpsyt.2023.1251955

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Search for serum biomarkers in patients with bipolar disorder and major depressive disorder using metabolome analysisPMID 37736060Read ↗

Metabolomic biomarkers related to non-suicidal self-injury in patients with bipolar disorderSemantic proximity Read ↗

The Metabolome-Wide Signature of Major Depressive DisorderSemantic proximity Read ↗

Differential urinary metabolites related with the severity of major depressive disorder.Semantic proximity Read ↗

Peripheral Metabolic-Redox Signaling as a Core Mechanism of Major Depressive Disorder: Evidence From Deep Metabolomic PhenotypingSemantic proximity Read ↗

Proteomic Insights into Biology of Bipolar Disorder: Implications for Health Complexity and MortalitySemantic proximity Read ↗

Integrated Multi-Omics Analysis of Gut Microbiome and Serum Metabolome in Unipolar and Bipolar DepressionSemantic proximity Read ↗

Transformations in Plasma Metabolic Profiles of Patients with Major Depression During Treatment: A Pilot Metabolomics StudySemantic proximity Read ↗

Advances in biomarkers of major depressive disorder.Semantic proximity Read ↗

The Potential Biomarker Panels for Identification of Major Depressive Disorder (MDD) Patients with and without Early Life Stress (ELS) by Metabonomic AnalysisSemantic proximity Read ↗

Identification of Sex-Specific Plasma Biomarkers Using Metabolomics for Major Depressive Disorder in Children and AdolescentsSemantic proximity Read ↗

A review of new insights into existing major depressive disorder biomarkersSemantic proximity Read ↗

Peripheral metabolic-redox signaling as a core mechanism of major depressive disorder: evidence from deep metabolomic phenotyping.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.